fanta.bio Sample: CNhs11965
18263 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1273 / 17412 (7.3%) | 418 / 174120 (0.2%) | −324.0 | −324.0 | 30.45 |
| HIF1A SRX11007095 | HK-2 Kidney | 2480 / 17412 (14.2%) | 886 / 174120 (0.5%) | −324.0 | −324.0 | 27.99 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1875 / 17412 (10.8%) | 730 / 174120 (0.4%) | −324.0 | −324.0 | 25.68 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1806 / 17412 (10.4%) | 778 / 174120 (0.4%) | −324.0 | −324.0 | 23.21 |
| HIF1A SRX20663235 | HK-2 Kidney | 569 / 17412 (3.3%) | 254 / 174120 (0.1%) | −324.0 | −324.0 | 22.40 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2565 / 17412 (14.7%) | 1167 / 174120 (0.7%) | −324.0 | −324.0 | 21.98 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2475 / 17412 (14.2%) | 1153 / 174120 (0.7%) | −324.0 | −324.0 | 21.47 |
| TP53 SRX19538279 | Osteoblasts Bone | 545 / 17412 (3.1%) | 285 / 174120 (0.2%) | −324.0 | −324.0 | 19.12 |
| SCML2 SRX644728 | 293 Kidney | 1464 / 17412 (8.4%) | 768 / 174120 (0.4%) | −324.0 | −324.0 | 19.06 |
| FOXP1 SRX736067 | LNCAP Prostate | 2069 / 17412 (11.9%) | 1116 / 174120 (0.6%) | −324.0 | −324.0 | 18.54 |
| MYH11 SRX265221 | ME-1 Blood | 972 / 17412 (5.6%) | 588 / 174120 (0.3%) | −324.0 | −324.0 | 16.53 |
| BRD4 SRX9419935 | BT-474 Breast | 3985 / 17412 (22.9%) | 2781 / 174120 (1.6%) | −324.0 | −324.0 | 14.33 |
| MED1 SRX9419945 | BT-474 Breast | 3969 / 17412 (22.8%) | 2810 / 174120 (1.6%) | −324.0 | −324.0 | 14.12 |
| MED1 SRX9419944 | BT-474 Breast | 3874 / 17412 (22.2%) | 2761 / 174120 (1.6%) | −324.0 | −324.0 | 14.03 |
| BRD4 SRX9419937 | BT-474 Breast | 3944 / 17412 (22.7%) | 2829 / 174120 (1.6%) | −324.0 | −324.0 | 13.94 |
| BRD4 SRX9419936 | BT-474 Breast | 4030 / 17412 (23.1%) | 2917 / 174120 (1.7%) | −324.0 | −324.0 | 13.82 |
| MED1 SRX9419946 | BT-474 Breast | 4028 / 17412 (23.1%) | 2946 / 174120 (1.7%) | −324.0 | −324.0 | 13.67 |
| BRD4 SRX9419938 | BT-474 Breast | 4001 / 17412 (23.0%) | 2945 / 174120 (1.7%) | −324.0 | −324.0 | 13.59 |
| MED1 SRX9419947 | BT-474 Breast | 3883 / 17412 (22.3%) | 2922 / 174120 (1.7%) | −324.0 | −324.0 | 13.29 |
| EZH2 SRX2146136 | LNCAP Prostate | 8562 / 17412 (49.2%) | 8188 / 174120 (4.7%) | −324.0 | −324.0 | 10.46 |
| BRD4 SRX736201 | 90-8TL Neural | 6447 / 17412 (37.0%) | 6820 / 174120 (3.9%) | −324.0 | −324.0 | 9.45 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 756 / 17412 (4.3%) | 928 / 174120 (0.5%) | −324.0 | −324.0 | 8.15 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1968 / 17412 (11.3%) | 2811 / 174120 (1.6%) | −324.0 | −324.0 | 7.00 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1578 / 17412 (9.1%) | 3694 / 174120 (2.1%) | −324.0 | −324.0 | 4.27 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1707 / 17412 (9.8%) | 5206 / 174120 (3.0%) | −324.0 | −324.0 | 3.28 |
| AGO2 SRX4708039 | Hep G2 Liver | 2115 / 17412 (12.1%) | 7648 / 174120 (4.4%) | −324.0 | −324.0 | 2.77 |
| PBX4 SRX2731658 | PC-3 Prostate | 937 / 17412 (5.4%) | 27527 / 174120 (15.8%) | −324.0 | −324.0 | 0.34 |
| TP53 SRX19538274 | U2OS Bone | 451 / 17412 (2.6%) | 172 / 174120 (0.1%) | −320.9 | −317.9 | 26.22 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 736 / 17412 (4.2%) | 929 / 174120 (0.5%) | −315.0 | −311.9 | 7.92 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 760 / 17412 (4.4%) | 1019 / 174120 (0.6%) | −313.0 | −309.9 | 7.46 |
| TP53 SRX19538268 | U2OS Bone | 443 / 17412 (2.5%) | 178 / 174120 (0.1%) | −310.6 | −307.6 | 24.89 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 461 / 17412 (2.6%) | 217 / 174120 (0.1%) | −308.1 | −305.1 | 21.24 |
| YAP1 SRX757325 | H2052 Lung | 659 / 17412 (3.8%) | 21198 / 174120 (12.2%) | −307.7 | −304.7 | 0.31 |
| TP53 SRX19538276 | U2OS Bone | 432 / 17412 (2.5%) | 183 / 174120 (0.1%) | −298.2 | −295.3 | 23.61 |
| FOS SRX150477 | MCF 10A Breast | 643 / 17412 (3.7%) | 20484 / 174120 (11.8%) | −293.3 | −290.3 | 0.31 |
| FOS SRX150478 | MCF 10A Breast | 682 / 17412 (3.9%) | 20933 / 174120 (12.0%) | −287.8 | −284.8 | 0.33 |
| YAP1 SRX757326 | H2052 Lung | 567 / 17412 (3.3%) | 18986 / 174120 (10.9%) | −285.2 | −282.2 | 0.30 |
| TP53 SRX19538280 | Osteoblasts Bone | 427 / 17412 (2.5%) | 214 / 174120 (0.1%) | −279.6 | −276.6 | 19.95 |
| TP53 SRX19538267 | U2OS Bone | 390 / 17412 (2.2%) | 156 / 174120 (0.1%) | −273.7 | −270.8 | 25.00 |
| TP53 SRX19538275 | U2OS Bone | 398 / 17412 (2.3%) | 174 / 174120 (0.1%) | −272.1 | −269.2 | 22.87 |
| TP53 SRX19538273 | U2OS Bone | 386 / 17412 (2.2%) | 157 / 174120 (0.1%) | −269.6 | −266.7 | 24.59 |
| FOXA1 SRX4815198 | MCF-7 Breast | 984 / 17412 (5.7%) | 24896 / 174120 (14.3%) | −269.2 | −266.3 | 0.40 |
| IRF3 SRX11453858 | Hep G2 Liver | 330 / 17412 (1.9%) | 76 / 174120 (0.0%) | −264.3 | −261.4 | 43.42 |
| TP53 SRX19538281 | Osteoblasts Bone | 451 / 17412 (2.6%) | 306 / 174120 (0.2%) | −264.0 | −261.2 | 14.74 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 642 / 17412 (3.7%) | 19385 / 174120 (11.1%) | −259.6 | −256.7 | 0.33 |
| BRD1 SRX286203 | RKO Digestive tract | 1351 / 17412 (7.8%) | 4172 / 174120 (2.4%) | −257.2 | −254.4 | 3.24 |
| KAT7 SRX101303 | RKO Digestive tract | 1532 / 17412 (8.8%) | 5194 / 174120 (3.0%) | −257.0 | −254.2 | 2.95 |
| Epitope tags SRX10549776 | K-562 Blood | 1542 / 17412 (8.9%) | 5257 / 174120 (3.0%) | −256.6 | −253.8 | 2.93 |
| FOXA1 SRX4815197 | MCF-7 Breast | 731 / 17412 (4.2%) | 20442 / 174120 (11.7%) | −249.7 | −246.8 | 0.36 |
| TP53 SRX19538269 | U2OS Bone | 478 / 17412 (2.7%) | 434 / 174120 (0.2%) | −245.4 | −242.5 | 11.01 |
| FOXA1 SRX176862 | MCF-7 Breast | 363 / 17412 (2.1%) | 14264 / 174120 (8.2%) | −245.0 | −242.2 | 0.25 |
| FOXA1 SRX176863 | MCF-7 Breast | 333 / 17412 (1.9%) | 13642 / 174120 (7.8%) | −242.3 | −239.5 | 0.24 |
| FOS SRX4192880 | MCF 10A Breast | 506 / 17412 (2.9%) | 16612 / 174120 (9.5%) | −241.8 | −239.0 | 0.30 |
| ESR1 SRX7624157 | MCF-7 Breast | 799 / 17412 (4.6%) | 21164 / 174120 (12.2%) | −240.7 | −237.9 | 0.38 |
| BRPF3 SRX796085 | RKO Digestive tract | 1214 / 17412 (7.0%) | 3667 / 174120 (2.1%) | −237.2 | −234.4 | 3.31 |
| 5-mC SRX882970 | LNCAP Prostate | 3024 / 17412 (17.4%) | 15672 / 174120 (9.0%) | −233.5 | −230.7 | 1.93 |
| RUNX1 SRX2513054 | 293 Kidney | 3366 / 17412 (19.3%) | 18318 / 174120 (10.5%) | −230.9 | −228.1 | 1.84 |
| IRF3 SRX11453861 | Hep G2 Liver | 293 / 17412 (1.7%) | 76 / 174120 (0.0%) | −229.0 | −226.2 | 38.55 |
| BRPF3 SRX796084 | RKO Digestive tract | 1644 / 17412 (9.4%) | 6306 / 174120 (3.6%) | −227.3 | −224.6 | 2.61 |
| ESR1 SRX20282961 | MCF-7 Breast | 378 / 17412 (2.2%) | 13977 / 174120 (8.0%) | −227.0 | −224.2 | 0.27 |
| TP53 SRX19538270 | U2OS Bone | 454 / 17412 (2.6%) | 435 / 174120 (0.2%) | −226.7 | −224.0 | 10.44 |
| GATA3 SRX190239 | MCF-7 Breast | 444 / 17412 (2.5%) | 15075 / 174120 (8.7%) | −226.1 | −223.4 | 0.29 |
| FOXA1 SRX3931044 | MCF-7 Breast | 679 / 17412 (3.9%) | 18810 / 174120 (10.8%) | −225.3 | −222.6 | 0.36 |
| FOXA1 SRX1161177 | MCF-7 Breast | 291 / 17412 (1.7%) | 12346 / 174120 (7.1%) | −224.5 | −221.8 | 0.24 |
| 5-mC SRX882968 | LNCAP Prostate | 2976 / 17412 (17.1%) | 15549 / 174120 (8.9%) | −224.5 | −221.7 | 1.91 |
| ESR1 SRX4367193 | MCF-7 Breast | 1058 / 17412 (6.1%) | 24300 / 174120 (14.0%) | −223.7 | −221.0 | 0.44 |
| BRPF3 SRX796086 | RKO Digestive tract | 1576 / 17412 (9.1%) | 5986 / 174120 (3.4%) | −221.2 | −218.5 | 2.63 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 542 / 17412 (3.1%) | 736 / 174120 (0.4%) | −220.7 | −218.0 | 7.36 |
| ESR1 SRX371478 | MCF-7 Breast | 399 / 17412 (2.3%) | 14123 / 174120 (8.1%) | −220.0 | −217.3 | 0.28 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 541 / 17412 (3.1%) | 16409 / 174120 (9.4%) | −218.3 | −215.6 | 0.33 |
| FOXA1 SRX1161176 | MCF-7 Breast | 279 / 17412 (1.6%) | 11929 / 174120 (6.9%) | −217.9 | −215.3 | 0.23 |
| AGO2 SRX6783958 | Hep G2 Liver | 1329 / 17412 (7.6%) | 4558 / 174120 (2.6%) | −217.9 | −215.3 | 2.92 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1133 / 17412 (6.5%) | 25116 / 174120 (14.4%) | −217.5 | −214.9 | 0.45 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 787 / 17412 (4.5%) | 20155 / 174120 (11.6%) | −217.2 | −214.6 | 0.39 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 364 / 17412 (2.1%) | 13418 / 174120 (7.7%) | −216.7 | −214.1 | 0.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 289 / 17412 (1.7%) | 12051 / 174120 (6.9%) | −215.8 | −213.2 | 0.24 |
| FOS SRX150517 | MCF 10A Breast | 559 / 17412 (3.2%) | 16615 / 174120 (9.5%) | −215.8 | −213.2 | 0.34 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 213 / 17412 (1.2%) | 10610 / 174120 (6.1%) | −215.7 | −213.0 | 0.20 |
| ESR1 SRX371469 | MCF-7 Breast | 319 / 17412 (1.8%) | 12554 / 174120 (7.2%) | −214.4 | −211.8 | 0.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 226 / 17412 (1.3%) | 10782 / 174120 (6.2%) | −212.9 | −210.3 | 0.21 |
| GATA3 SRX190194 | SK-N-SH Neural | 785 / 17412 (4.5%) | 19957 / 174120 (11.5%) | −212.5 | −209.8 | 0.39 |
| AGO2 SRX6783957 | Hep G2 Liver | 1331 / 17412 (7.6%) | 4652 / 174120 (2.7%) | −212.0 | −209.4 | 2.86 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 798 / 17412 (4.6%) | 20125 / 174120 (11.6%) | −211.8 | −209.2 | 0.40 |
| ESR1 SRX7624156 | MCF-7 Breast | 519 / 17412 (3.0%) | 15798 / 174120 (9.1%) | −210.4 | −207.8 | 0.33 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 784 / 17412 (4.5%) | 19836 / 174120 (11.4%) | −209.6 | −207.0 | 0.40 |
| AR SRX10820653 | LNCAP Prostate | 346 / 17412 (2.0%) | 216 / 174120 (0.1%) | −209.3 | −206.7 | 16.02 |
| TP53 SRX396254 | Fibroblasts Others | 988 / 17412 (5.7%) | 2789 / 174120 (1.6%) | −209.2 | −206.6 | 3.54 |
| FOXA1 SRX371481 | MCF-7 Breast | 334 / 17412 (1.9%) | 12625 / 174120 (7.3%) | −208.1 | −205.5 | 0.26 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 465 / 17412 (2.7%) | 14802 / 174120 (8.5%) | −206.7 | −204.2 | 0.31 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 299 / 17412 (1.7%) | 11955 / 174120 (6.9%) | −206.7 | −204.1 | 0.25 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 380 / 17412 (2.2%) | 13354 / 174120 (7.7%) | −205.9 | −203.3 | 0.28 |
| BRD4 SRX736204 | 90-8TL Neural | 1009 / 17412 (5.8%) | 2941 / 174120 (1.7%) | −205.4 | −202.8 | 3.43 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2157 / 17412 (12.4%) | 10106 / 174120 (5.8%) | −205.4 | −202.8 | 2.13 |
| KAT6A SRX20971022 | Fibroblasts Others | 270 / 17412 (1.6%) | 80 / 174120 (0.0%) | −204.8 | −202.3 | 33.75 |
| FOXA1 SRX371482 | MCF-7 Breast | 481 / 17412 (2.8%) | 14991 / 174120 (8.6%) | −204.7 | −202.1 | 0.32 |
| TP53 SRX19538282 | Osteoblasts Bone | 382 / 17412 (2.2%) | 322 / 174120 (0.2%) | −203.2 | −200.7 | 11.86 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 486 / 17412 (2.8%) | 15026 / 174120 (8.6%) | −203.2 | −200.7 | 0.32 |
| JUNB SRX8488088 | SUM 229PE Breast | 660 / 17412 (3.8%) | 17745 / 174120 (10.2%) | −203.1 | −200.6 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 321 / 17412 (1.8%) | 12237 / 174120 (7.0%) | −203.0 | −200.5 | 0.26 |
| ESR1 SRX176861 | MCF-7 Breast | 555 / 17412 (3.2%) | 16111 / 174120 (9.3%) | −202.7 | −200.2 | 0.34 |
| ING5 SRX286202 | RKO Digestive tract | 1415 / 17412 (8.1%) | 5293 / 174120 (3.0%) | −202.6 | −200.1 | 2.67 |
| ESR1 SRX176860 | MCF-7 Breast | 554 / 17412 (3.2%) | 16088 / 174120 (9.2%) | −202.6 | −200.1 | 0.34 |
| FOXA1 SRX371483 | MCF-7 Breast | 373 / 17412 (2.1%) | 13101 / 174120 (7.5%) | −201.7 | −199.2 | 0.28 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1162 / 17412 (6.7%) | 24873 / 174120 (14.3%) | −201.3 | −198.8 | 0.47 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 423 / 17412 (2.4%) | 13867 / 174120 (8.0%) | −199.3 | −196.8 | 0.31 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 745 / 17412 (4.3%) | 18885 / 174120 (10.8%) | −199.3 | −196.8 | 0.39 |
| ESR1 SRX20282960 | MCF-7 Breast | 379 / 17412 (2.2%) | 13119 / 174120 (7.5%) | −199.0 | −196.5 | 0.29 |
| 5-mC SRX882965 | LNCAP Prostate | 2417 / 17412 (13.9%) | 12109 / 174120 (7.0%) | −198.4 | −195.9 | 2.00 |
| FOS SRX150476 | MCF 10A Breast | 600 / 17412 (3.4%) | 16612 / 174120 (9.5%) | −197.0 | −194.5 | 0.36 |
| FOXA1 SRX1161175 | MCF-7 Breast | 232 / 17412 (1.3%) | 10423 / 174120 (6.0%) | −196.8 | −194.3 | 0.22 |
| ESR1 SRX371471 | ZR-75-1 Breast | 362 / 17412 (2.1%) | 12743 / 174120 (7.3%) | −196.4 | −193.9 | 0.28 |
| ESR1 SRX371470 | ZR-75-1 Breast | 299 / 17412 (1.7%) | 11623 / 174120 (6.7%) | −195.8 | −193.3 | 0.26 |
| ESR1 SRX194569 | MCF-7 Breast | 342 / 17412 (2.0%) | 12374 / 174120 (7.1%) | −195.7 | −193.2 | 0.28 |
| YAP1 SRX5718140 | 293 Kidney | 580 / 17412 (3.3%) | 16252 / 174120 (9.3%) | −195.5 | −193.0 | 0.36 |
| ESR1 SRX371479 | MCF-7 Breast | 307 / 17412 (1.8%) | 11745 / 174120 (6.7%) | −195.0 | −192.6 | 0.26 |
| TCF12 SRX190356 | SK-N-SH Neural | 956 / 17412 (5.5%) | 21761 / 174120 (12.5%) | −194.7 | −192.3 | 0.44 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 429 / 17412 (2.5%) | 13806 / 174120 (7.9%) | −194.5 | −192.0 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 559 / 17412 (3.2%) | 949 / 174120 (0.5%) | −193.7 | −191.2 | 5.89 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 678 / 17412 (3.9%) | 17680 / 174120 (10.2%) | −193.6 | −191.1 | 0.38 |
| SS18 SRX3468047 | Fibroblasts Others | 887 / 17412 (5.1%) | 20732 / 174120 (11.9%) | −193.4 | −191.0 | 0.43 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 743 / 17412 (4.3%) | 18635 / 174120 (10.7%) | −193.3 | −190.9 | 0.40 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 516 / 17412 (3.0%) | 791 / 174120 (0.5%) | −193.1 | −190.6 | 6.52 |
| FOXA1 SRX100454 | T-47D Breast | 442 / 17412 (2.5%) | 13956 / 174120 (8.0%) | −192.5 | −190.1 | 0.32 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 673 / 17412 (3.9%) | 1429 / 174120 (0.8%) | −192.5 | −190.1 | 4.71 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 273 / 17412 (1.6%) | 109 / 174120 (0.1%) | −191.7 | −189.3 | 25.05 |
| ESR1 SRX20282939 | MCF-7 Breast | 394 / 17412 (2.3%) | 13107 / 174120 (7.5%) | −190.9 | −188.5 | 0.30 |
| ESR1 SRX371467 | MCF-7 Breast | 353 / 17412 (2.0%) | 12405 / 174120 (7.1%) | −190.5 | −188.1 | 0.28 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1298 / 17412 (7.5%) | 26175 / 174120 (15.0%) | −188.2 | −185.8 | 0.50 |
| GATA3 SRX176864 | MCF-7 Breast | 234 / 17412 (1.3%) | 10193 / 174120 (5.9%) | −187.7 | −185.3 | 0.23 |
| ESR1 SRX371476 | MCF-7 Breast | 243 / 17412 (1.4%) | 10352 / 174120 (5.9%) | −187.5 | −185.1 | 0.23 |
| JUN SRX17561461 | LPS141 Adipocyte | 510 / 17412 (2.9%) | 14876 / 174120 (8.5%) | −187.4 | −185.0 | 0.34 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 308 / 17412 (1.8%) | 11480 / 174120 (6.6%) | −186.1 | −183.7 | 0.27 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 308 / 17412 (1.8%) | 11481 / 174120 (6.6%) | −186.1 | −183.7 | 0.27 |
| ESR1 SRX1531791 | MCF-7 Breast | 330 / 17412 (1.9%) | 11851 / 174120 (6.8%) | −185.7 | −183.3 | 0.28 |
| GATA3 SRX5057632 | MCF-7 Breast | 206 / 17412 (1.2%) | 9594 / 174120 (5.5%) | −185.5 | −183.1 | 0.21 |
| SMARCA2 SRX8119677 | MeT-5A Others | 581 / 17412 (3.3%) | 15901 / 174120 (9.1%) | −185.0 | −182.6 | 0.37 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1070 / 17412 (6.1%) | 22932 / 174120 (13.2%) | −184.2 | −181.8 | 0.47 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 339 / 17412 (1.9%) | 11949 / 174120 (6.9%) | −183.9 | −181.5 | 0.28 |
| MEAF6 DRX300417 | 293 Kidney | 1606 / 17412 (9.2%) | 6831 / 174120 (3.9%) | −183.6 | −181.3 | 2.35 |
| TP53 SRX19538271 | U2OS Bone | 619 / 17412 (3.6%) | 1265 / 174120 (0.7%) | −183.3 | −181.0 | 4.89 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 580 / 17412 (3.3%) | 15825 / 174120 (9.1%) | −183.3 | −180.9 | 0.37 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 952 / 17412 (5.5%) | 21250 / 174120 (12.2%) | −183.0 | −180.7 | 0.45 |
| AR SRX1067071 | LHSAR Prostate | 715 / 17412 (4.1%) | 17845 / 174120 (10.2%) | −183.0 | −180.6 | 0.40 |
| ESR1 SRX194572 | MCF-7 Breast | 204 / 17412 (1.2%) | 9480 / 174120 (5.4%) | −182.9 | −180.6 | 0.22 |
| Epitope tags DRX443510 | 293 Kidney | 1520 / 17412 (8.7%) | 6286 / 174120 (3.6%) | −182.9 | −180.5 | 2.42 |
| FOXA1 SRX11222441 | MCF-7 Breast | 252 / 17412 (1.4%) | 10369 / 174120 (6.0%) | −182.6 | −180.2 | 0.24 |
| MEAF6 DRX234811 | 293 Kidney | 1735 / 17412 (10.0%) | 7710 / 174120 (4.4%) | −182.5 | −180.1 | 2.25 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 666 / 17412 (3.8%) | 1479 / 174120 (0.8%) | −182.4 | −180.1 | 4.50 |
| ESR1 SRX371468 | MCF-7 Breast | 208 / 17412 (1.2%) | 9540 / 174120 (5.5%) | −182.4 | −180.1 | 0.22 |
| RAC1 SRX10365541 | MCF-7 Breast | 161 / 17412 (0.9%) | 8612 / 174120 (4.9%) | −182.2 | −179.8 | 0.19 |
| FOXA1 SRX371480 | MCF-7 Breast | 224 / 17412 (1.3%) | 9837 / 174120 (5.6%) | −182.1 | −179.7 | 0.23 |
| CIC SRX13262055 | Astrocytes Neural | 3038 / 17412 (17.4%) | 17225 / 174120 (9.9%) | −181.9 | −179.6 | 1.76 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1412 / 17412 (8.1%) | 5624 / 174120 (3.2%) | −181.5 | −179.2 | 2.51 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1168 / 17412 (6.7%) | 24151 / 174120 (13.9%) | −181.5 | −179.1 | 0.48 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 310 / 17412 (1.8%) | 11358 / 174120 (6.5%) | −181.0 | −178.6 | 0.27 |
| ESR1 SRX20282954 | MCF-7 Breast | 390 / 17412 (2.2%) | 12691 / 174120 (7.3%) | −180.1 | −177.8 | 0.31 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 471 / 17412 (2.7%) | 13981 / 174120 (8.0%) | −179.3 | −177.0 | 0.34 |
| ESR1 SRX10365536 | MCF-7 Breast | 162 / 17412 (0.9%) | 8526 / 174120 (4.9%) | −178.6 | −176.2 | 0.19 |
| SMARCA4 SRX5212362 | Mel270 Others | 630 / 17412 (3.6%) | 16416 / 174120 (9.4%) | −178.6 | −176.2 | 0.38 |
| CEBPB SRX150632 | HeLa Uterus | 836 / 17412 (4.8%) | 19420 / 174120 (11.2%) | −178.2 | −175.8 | 0.43 |
| ARID1A SRX5089376 | MCF-7 Breast | 300 / 17412 (1.7%) | 11078 / 174120 (6.4%) | −177.8 | −175.5 | 0.27 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1426 / 17412 (8.2%) | 27408 / 174120 (15.7%) | −177.7 | −175.4 | 0.52 |
| ESR1 SRX20282972 | MCF-7 Breast | 404 / 17412 (2.3%) | 12833 / 174120 (7.4%) | −177.4 | −175.1 | 0.31 |
| RAC1 SRX10365543 | MCF-7 Breast | 166 / 17412 (1.0%) | 8568 / 174120 (4.9%) | −177.1 | −174.8 | 0.19 |
| FOXA1 SRX1787653 | MCF-7 Breast | 277 / 17412 (1.6%) | 10647 / 174120 (6.1%) | −176.8 | −174.5 | 0.26 |
| ARID5B SRX3230377 | Hep G2 Liver | 919 / 17412 (5.3%) | 20530 / 174120 (11.8%) | −176.6 | −174.3 | 0.45 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 714 / 17412 (4.1%) | 17567 / 174120 (10.1%) | −176.0 | −173.7 | 0.41 |
| FOS SRX4192879 | MCF 10A Breast | 426 / 17412 (2.4%) | 13123 / 174120 (7.5%) | −175.4 | −173.1 | 0.32 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1065 / 17412 (6.1%) | 22474 / 174120 (12.9%) | −174.7 | −172.4 | 0.47 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 270 / 17412 (1.6%) | 10451 / 174120 (6.0%) | −174.6 | −172.3 | 0.26 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 294 / 17412 (1.7%) | 10874 / 174120 (6.2%) | −174.5 | −172.2 | 0.27 |
| AR SRX1067070 | LHSAR Prostate | 912 / 17412 (5.2%) | 20345 / 174120 (11.7%) | −174.4 | −172.1 | 0.45 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 722 / 17412 (4.1%) | 17626 / 174120 (10.1%) | −174.3 | −172.1 | 0.41 |
| ESR1 SRX2943591 | MCF-7 Breast | 236 / 17412 (1.4%) | 9822 / 174120 (5.6%) | −174.2 | −171.9 | 0.24 |
| JUN SRX4192884 | MCF 10A Breast | 293 / 17412 (1.7%) | 10825 / 174120 (6.2%) | −173.5 | −171.3 | 0.27 |
| FOXA2 SRX3230382 | Hep G2 Liver | 489 / 17412 (2.8%) | 14065 / 174120 (8.1%) | −173.5 | −171.2 | 0.35 |
| AR SRX10820651 | LNCAP Prostate | 350 / 17412 (2.0%) | 340 / 174120 (0.2%) | −173.5 | −171.2 | 10.29 |
| FOXA1 SRX11222437 | MCF-7 Breast | 246 / 17412 (1.4%) | 9971 / 174120 (5.7%) | −173.0 | −170.8 | 0.25 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 372 / 17412 (2.1%) | 12155 / 174120 (7.0%) | −173.0 | −170.7 | 0.31 |
| SMARCA4 SRX5212366 | Mel270 Others | 497 / 17412 (2.9%) | 14126 / 174120 (8.1%) | −171.6 | −169.3 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 367 / 17412 (2.1%) | 12025 / 174120 (6.9%) | −171.6 | −169.3 | 0.31 |
| ESR1 SRX20282973 | MCF-7 Breast | 444 / 17412 (2.5%) | 13280 / 174120 (7.6%) | −171.5 | −169.2 | 0.33 |
| ESR1 SRX10365535 | MCF-7 Breast | 282 / 17412 (1.6%) | 10565 / 174120 (6.1%) | −171.4 | −169.2 | 0.27 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 280 / 17412 (1.6%) | 10518 / 174120 (6.0%) | −171.1 | −168.8 | 0.27 |
| FOXA1 SRX3931043 | MCF-7 Breast | 368 / 17412 (2.1%) | 12020 / 174120 (6.9%) | −171.0 | −168.7 | 0.31 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 248 / 17412 (1.4%) | 9937 / 174120 (5.7%) | −170.8 | −168.6 | 0.25 |
| STAT5B SRX831881 | CD8+ T cells Blood | 268 / 17412 (1.5%) | 148 / 174120 (0.1%) | −169.7 | −167.5 | 18.11 |
| SMARCA4 SRX5212357 | Mel270 Others | 542 / 17412 (3.1%) | 14753 / 174120 (8.5%) | −169.5 | −167.3 | 0.37 |
| ESR1 SRX4367192 | MCF-7 Breast | 761 / 17412 (4.4%) | 18005 / 174120 (10.3%) | −169.4 | −167.2 | 0.42 |
| LEO1 SRX1873456 | SEM Blood | 1493 / 17412 (8.6%) | 6366 / 174120 (3.7%) | −169.3 | −167.1 | 2.35 |
| FOXA1 SRX11222442 | MCF-7 Breast | 234 / 17412 (1.3%) | 9608 / 174120 (5.5%) | −168.5 | −166.2 | 0.24 |
| JUNB SRX8488073 | SUM 229PE Breast | 713 / 17412 (4.1%) | 17270 / 174120 (9.9%) | −168.4 | −166.1 | 0.41 |
| FOXA1 SRX3931055 | MCF-7 Breast | 301 / 17412 (1.7%) | 10779 / 174120 (6.2%) | −167.8 | −165.6 | 0.28 |
| ARID1A SRX5089379 | MCF-7 Breast | 360 / 17412 (2.1%) | 11781 / 174120 (6.8%) | −167.8 | −165.5 | 0.31 |
| JUNB SRX10119386 | MCF 10A Breast | 334 / 17412 (1.9%) | 11332 / 174120 (6.5%) | −167.3 | −165.1 | 0.29 |
| VGLL1 SRX24602130 | BT-20 Breast | 388 / 17412 (2.2%) | 12232 / 174120 (7.0%) | −167.3 | −165.1 | 0.32 |
| ESR1 SRX20282955 | MCF-7 Breast | 394 / 17412 (2.3%) | 12309 / 174120 (7.1%) | −166.7 | −164.4 | 0.32 |
| GATA3 SRX6712581 | MCF-7 Breast | 295 / 17412 (1.7%) | 10637 / 174120 (6.1%) | −166.6 | −164.4 | 0.28 |
| GATAD2A SRX2636506 | Hep G2 Liver | 476 / 17412 (2.7%) | 13610 / 174120 (7.8%) | −166.3 | −164.1 | 0.35 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 661 / 17412 (3.8%) | 16412 / 174120 (9.4%) | −165.8 | −163.6 | 0.40 |
| SMARCA4 SRX5212371 | Mel270 Others | 535 / 17412 (3.1%) | 14510 / 174120 (8.3%) | −165.7 | −163.5 | 0.37 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 408 / 17412 (2.3%) | 12488 / 174120 (7.2%) | −165.2 | −163.0 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 169 / 17412 (1.0%) | 8259 / 174120 (4.7%) | −164.5 | −162.3 | 0.20 |
| FOXA1 SRX3931054 | MCF-7 Breast | 342 / 17412 (2.0%) | 11363 / 174120 (6.5%) | −164.1 | −161.9 | 0.30 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 330 / 17412 (1.9%) | 11153 / 174120 (6.4%) | −163.9 | −161.7 | 0.30 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 162 / 17412 (0.9%) | 8101 / 174120 (4.7%) | −163.9 | −161.7 | 0.20 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 817 / 17412 (4.7%) | 2407 / 174120 (1.4%) | −163.4 | −161.2 | 3.39 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 406 / 17412 (2.3%) | 12389 / 174120 (7.1%) | −163.3 | −161.1 | 0.33 |
| GATA3 SRX5457550 | MCF-7 Breast | 423 / 17412 (2.4%) | 12662 / 174120 (7.3%) | −163.3 | −161.1 | 0.33 |
| AR SRX9469988 | LAPC-4 Prostate | 510 / 17412 (2.9%) | 14029 / 174120 (8.1%) | −163.2 | −161.0 | 0.36 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 345 / 17412 (2.0%) | 11365 / 174120 (6.5%) | −162.7 | −160.6 | 0.30 |
| Epitope tags SRX10549778 | K-562 Blood | 1131 / 17412 (6.5%) | 4202 / 174120 (2.4%) | −162.6 | −160.4 | 2.69 |
| TLE3 SRX4815192 | MCF-7 Breast | 337 / 17412 (1.9%) | 11220 / 174120 (6.4%) | −162.4 | −160.2 | 0.30 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1354 / 17412 (7.8%) | 25789 / 174120 (14.8%) | −162.2 | −160.0 | 0.53 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 907 / 17412 (5.2%) | 2911 / 174120 (1.7%) | −162.0 | −159.9 | 3.12 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1726 / 17412 (9.9%) | 8084 / 174120 (4.6%) | −162.0 | −159.8 | 2.14 |
| ESR1 SRX20282940 | MCF-7 Breast | 414 / 17412 (2.4%) | 12475 / 174120 (7.2%) | −162.0 | −159.8 | 0.33 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 695 / 17412 (4.0%) | 1803 / 174120 (1.0%) | −161.6 | −159.5 | 3.85 |
| ESR1 SRX10365532 | MCF-7 Breast | 187 / 17412 (1.1%) | 8524 / 174120 (4.9%) | −161.6 | −159.4 | 0.22 |
| SOX13 SRX2636248 | Hep G2 Liver | 525 / 17412 (3.0%) | 14199 / 174120 (8.2%) | −161.4 | −159.2 | 0.37 |
| ESR1 SRX371475 | BT-474 Breast | 179 / 17412 (1.0%) | 8359 / 174120 (4.8%) | −161.3 | −159.1 | 0.21 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 358 / 17412 (2.1%) | 11537 / 174120 (6.6%) | −161.3 | −159.1 | 0.31 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 450 / 17412 (2.6%) | 13023 / 174120 (7.5%) | −161.2 | −159.0 | 0.35 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 967 / 17412 (5.6%) | 20575 / 174120 (11.8%) | −161.1 | −159.0 | 0.47 |
| NR2F2 SRX190293 | MCF-7 Breast | 396 / 17412 (2.3%) | 12152 / 174120 (7.0%) | −161.1 | −158.9 | 0.33 |
| ESR1 SRX330067 | MCF-7 Breast | 336 / 17412 (1.9%) | 11153 / 174120 (6.4%) | −160.9 | −158.7 | 0.30 |
| FOXA1 SRX1787652 | MCF-7 Breast | 217 / 17412 (1.2%) | 9063 / 174120 (5.2%) | −160.8 | −158.7 | 0.24 |
| ARID5B SRX10475139 | Hep G2 Liver | 409 / 17412 (2.3%) | 12341 / 174120 (7.1%) | −160.5 | −158.3 | 0.33 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 260 / 17412 (1.5%) | 9812 / 174120 (5.6%) | −159.9 | −157.8 | 0.26 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 359 / 17412 (2.1%) | 11503 / 174120 (6.6%) | −159.9 | −157.7 | 0.31 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1122 / 17412 (6.4%) | 22620 / 174120 (13.0%) | −159.8 | −157.6 | 0.50 |
| FOXA1 SRX15430999 | T-47D Breast | 423 / 17412 (2.4%) | 12538 / 174120 (7.2%) | −159.7 | −157.5 | 0.34 |
| TEAD1 SRX3401272 | MCF-7 Breast | 282 / 17412 (1.6%) | 10179 / 174120 (5.8%) | −159.3 | −157.2 | 0.28 |
| PBX3 SRX190343 | SK-N-SH Neural | 816 / 17412 (4.7%) | 18379 / 174120 (10.6%) | −158.9 | −156.7 | 0.44 |
| FOXA1 SRX028634 | MCF-7 Breast | 175 / 17412 (1.0%) | 8210 / 174120 (4.7%) | −158.8 | −156.6 | 0.21 |
| FOXA1 SRX11222438 | MCF-7 Breast | 189 / 17412 (1.1%) | 8469 / 174120 (4.9%) | −158.5 | −156.4 | 0.22 |
| ESR1 SRX20282946 | MCF-7 Breast | 219 / 17412 (1.3%) | 9029 / 174120 (5.2%) | −158.4 | −156.3 | 0.24 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 356 / 17412 (2.0%) | 11408 / 174120 (6.6%) | −158.4 | −156.2 | 0.31 |
| FOXA1 SRX5323843 | MCF-7 Breast | 185 / 17412 (1.1%) | 8387 / 174120 (4.8%) | −158.3 | −156.1 | 0.22 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 357 / 17412 (2.1%) | 11410 / 174120 (6.6%) | −158.1 | −156.0 | 0.31 |
| CEBPA SRX2630241 | Hep G2 Liver | 465 / 17412 (2.7%) | 13138 / 174120 (7.5%) | −157.8 | −155.7 | 0.35 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 351 / 17412 (2.0%) | 11298 / 174120 (6.5%) | −157.7 | −155.5 | 0.31 |
| FOXA1 SRX3923517 | MCF-7 Breast | 262 / 17412 (1.5%) | 9771 / 174120 (5.6%) | −157.5 | −155.4 | 0.27 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 371 / 17412 (2.1%) | 11611 / 174120 (6.7%) | −157.1 | −155.0 | 0.32 |
| EP300 SRX176885 | MCF-7 Breast | 187 / 17412 (1.1%) | 8387 / 174120 (4.8%) | −157.0 | −154.9 | 0.22 |
| FOXA1 SRX028635 | MCF-7 Breast | 177 / 17412 (1.0%) | 8188 / 174120 (4.7%) | −156.7 | −154.6 | 0.22 |
| BMI1 SRX644729 | 293 Kidney | 247 / 17412 (1.4%) | 138 / 174120 (0.1%) | −155.8 | −153.7 | 17.90 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 344 / 17412 (2.0%) | 11116 / 174120 (6.4%) | −155.7 | −153.6 | 0.31 |
| FOXA1 SRX3923516 | MCF-7 Breast | 270 / 17412 (1.6%) | 9853 / 174120 (5.7%) | −155.6 | −153.5 | 0.27 |
| PRRX1 SRX15235713 | Hs 578T Breast | 479 / 17412 (2.8%) | 13273 / 174120 (7.6%) | −155.4 | −153.3 | 0.36 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 559 / 17412 (3.2%) | 14486 / 174120 (8.3%) | −155.1 | −153.0 | 0.39 |
| ESR1 SRX2881000 | MCF-7 Breast | 334 / 17412 (1.9%) | 10925 / 174120 (6.3%) | −155.0 | −152.9 | 0.31 |
| KAT7 DRX234808 | 293 Kidney | 787 / 17412 (4.5%) | 2347 / 174120 (1.3%) | −154.9 | −152.7 | 3.35 |
| ESR1 SRX2881002 | MCF-7 Breast | 365 / 17412 (2.1%) | 11422 / 174120 (6.6%) | −154.5 | −152.4 | 0.32 |
| ESR1 SRX2943589 | MCF-7 Breast | 184 / 17412 (1.1%) | 8252 / 174120 (4.7%) | −154.4 | −152.3 | 0.22 |
| TRP47 SRX4548329 | THP-1 Blood | 2568 / 17412 (14.7%) | 14456 / 174120 (8.3%) | −154.1 | −152.0 | 1.78 |
| ARID5B SRX10475138 | Hep G2 Liver | 652 / 17412 (3.7%) | 15833 / 174120 (9.1%) | −154.1 | −152.0 | 0.41 |
| JUN SRX883584 | MDA-MB-231 Breast | 623 / 17412 (3.6%) | 15405 / 174120 (8.8%) | −154.1 | −151.9 | 0.40 |
| JUNB SRX8488089 | SUM 229PE Breast | 396 / 17412 (2.3%) | 11912 / 174120 (6.8%) | −154.0 | −151.9 | 0.33 |
| ESR1 SRX20282971 | MCF-7 Breast | 385 / 17412 (2.2%) | 11723 / 174120 (6.7%) | −153.8 | −151.7 | 0.33 |
| ESR1 SRX371474 | BT-474 Breast | 168 / 17412 (1.0%) | 7922 / 174120 (4.5%) | −153.6 | −151.5 | 0.21 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 511 / 17412 (2.9%) | 13706 / 174120 (7.9%) | −153.6 | −151.5 | 0.37 |
| JUNB SRX4192882 | MCF 10A Breast | 309 / 17412 (1.8%) | 10453 / 174120 (6.0%) | −153.4 | −151.3 | 0.30 |
| FOXA1 SRX1787655 | MCF-7 Breast | 182 / 17412 (1.0%) | 8178 / 174120 (4.7%) | −153.2 | −151.1 | 0.22 |
| FOXA1 SRX1161203 | T-47D Breast | 276 / 17412 (1.6%) | 9877 / 174120 (5.7%) | −153.1 | −151.0 | 0.28 |
| FOXA1 SRX1787651 | MCF-7 Breast | 210 / 17412 (1.2%) | 8688 / 174120 (5.0%) | −152.8 | −150.7 | 0.24 |
| STAT3 SRX2020842 | HCC70 Breast | 713 / 17412 (4.1%) | 16663 / 174120 (9.6%) | −152.7 | −150.6 | 0.43 |
| FOXA1 SRX3923518 | MCF-7 Breast | 263 / 17412 (1.5%) | 9635 / 174120 (5.5%) | −152.6 | −150.5 | 0.27 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 701 / 17412 (4.0%) | 16472 / 174120 (9.5%) | −152.2 | −150.1 | 0.43 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 510 / 17412 (2.9%) | 13626 / 174120 (7.8%) | −151.9 | −149.8 | 0.37 |
| GFP SRX6949256 | HeLa Uterus | 433 / 17412 (2.5%) | 12429 / 174120 (7.1%) | −151.9 | −149.8 | 0.35 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 597 / 17412 (3.4%) | 14935 / 174120 (8.6%) | −151.9 | −149.8 | 0.40 |
| FOXA2 SRX100448 | Hep G2 Liver | 435 / 17412 (2.5%) | 12454 / 174120 (7.2%) | −151.8 | −149.7 | 0.35 |
| WWTR1 SRX10119367 | MCF 10A Breast | 464 / 17412 (2.7%) | 12899 / 174120 (7.4%) | −151.5 | −149.4 | 0.36 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 180 / 17412 (1.0%) | 8087 / 174120 (4.6%) | −151.4 | −149.4 | 0.22 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 702 / 17412 (4.0%) | 16449 / 174120 (9.4%) | −151.2 | −149.2 | 0.43 |
| FOXA1 SRX100506 | Hep G2 Liver | 523 / 17412 (3.0%) | 13798 / 174120 (7.9%) | −151.1 | −149.1 | 0.38 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 368 / 17412 (2.1%) | 11357 / 174120 (6.5%) | −151.1 | −149.0 | 0.32 |
| JUN SRX6582171 | GM07492 Others | 776 / 17412 (4.5%) | 17498 / 174120 (10.0%) | −150.9 | −148.9 | 0.44 |
| FOXA1 SRX3931033 | MCF-7 Breast | 240 / 17412 (1.4%) | 9175 / 174120 (5.3%) | −150.9 | −148.8 | 0.26 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 820 / 17412 (4.7%) | 2575 / 174120 (1.5%) | −150.7 | −148.6 | 3.18 |
| JUND SRX150408 | HeLa Uterus | 351 / 17412 (2.0%) | 11065 / 174120 (6.4%) | −150.7 | −148.6 | 0.32 |
| AR SRX9109110 | MDA-MB-453 Breast | 758 / 17412 (4.4%) | 17210 / 174120 (9.9%) | −150.2 | −148.2 | 0.44 |
| ESR1 SRX3110725 | MCF-7 Breast | 349 / 17412 (2.0%) | 11015 / 174120 (6.3%) | −150.2 | −148.1 | 0.32 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 407 / 17412 (2.3%) | 11951 / 174120 (6.9%) | −150.0 | −147.9 | 0.34 |
| CDK9 SRX7366783 | MCF-7 Breast | 250 / 17412 (1.4%) | 160 / 174120 (0.1%) | −149.9 | −147.8 | 15.63 |
| ESR1 SRX20282953 | MCF-7 Breast | 321 / 17412 (1.8%) | 10539 / 174120 (6.1%) | −149.8 | −147.8 | 0.30 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 541 / 17412 (3.1%) | 14022 / 174120 (8.1%) | −149.8 | −147.7 | 0.39 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 350 / 17412 (2.0%) | 11006 / 174120 (6.3%) | −149.5 | −147.4 | 0.32 |
| FOXA1 SRX3923519 | MCF-7 Breast | 236 / 17412 (1.4%) | 9044 / 174120 (5.2%) | −149.1 | −147.0 | 0.26 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1115 / 17412 (6.4%) | 4322 / 174120 (2.5%) | −149.0 | −147.0 | 2.58 |
| ESR1 SRX330069 | MCF-7 Breast | 237 / 17412 (1.4%) | 9060 / 174120 (5.2%) | −149.0 | −147.0 | 0.26 |
| ESR1 SRX20282938 | MCF-7 Breast | 316 / 17412 (1.8%) | 10426 / 174120 (6.0%) | −149.0 | −146.9 | 0.30 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 374 / 17412 (2.1%) | 11383 / 174120 (6.5%) | −148.9 | −146.9 | 0.33 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 320 / 17412 (1.8%) | 10484 / 174120 (6.0%) | −148.7 | −146.7 | 0.31 |
| SSRP1 SRX3436567 | HT-1080 Bone | 397 / 17412 (2.3%) | 608 / 174120 (0.3%) | −148.6 | −146.5 | 6.53 |
| EP300 SRX150579 | HeLa Uterus | 265 / 17412 (1.5%) | 9538 / 174120 (5.5%) | −148.5 | −146.5 | 0.28 |
| ESR1 SRX5323873 | MCF-7 Breast | 490 / 17412 (2.8%) | 13194 / 174120 (7.6%) | −148.5 | −146.4 | 0.37 |
| EP300 SRX2671813 | Fibroblasts Others | 340 / 17412 (2.0%) | 10808 / 174120 (6.2%) | −148.4 | −146.4 | 0.31 |
| CEBPB SRX190345 | MCF-7 Breast | 308 / 17412 (1.8%) | 10261 / 174120 (5.9%) | −148.1 | −146.0 | 0.30 |
| Epitope tags SRX5877912 | U2OS Bone | 2215 / 17412 (12.7%) | 35819 / 174120 (20.6%) | −148.0 | −146.0 | 0.62 |
| FOXA1 SRX6878603 | LNCAP Prostate | 444 / 17412 (2.5%) | 12461 / 174120 (7.2%) | −147.9 | −145.8 | 0.36 |
| ESR1 SRX10365558 | MCF-7 Breast | 261 / 17412 (1.5%) | 9448 / 174120 (5.4%) | −147.8 | −145.8 | 0.28 |
| TFAP2C SRX128099 | MCF-7 Breast | 360 / 17412 (2.1%) | 11112 / 174120 (6.4%) | −147.8 | −145.7 | 0.32 |
| GATA3 SRX100559 | T-47D Breast | 448 / 17412 (2.6%) | 12519 / 174120 (7.2%) | −147.8 | −145.7 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 239 / 17412 (1.4%) | 9051 / 174120 (5.2%) | −147.6 | −145.6 | 0.26 |
| ESR1 SRX330070 | MCF-7 Breast | 198 / 17412 (1.1%) | 8307 / 174120 (4.8%) | −147.6 | −145.5 | 0.24 |
| TFAP2C SRX018833 | MCF-7 Breast | 361 / 17412 (2.1%) | 11121 / 174120 (6.4%) | −147.5 | −145.4 | 0.32 |
| FOXA1 SRX5323829 | T-47D Breast | 216 / 17412 (1.2%) | 8631 / 174120 (5.0%) | −147.3 | −145.3 | 0.25 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 520 / 17412 (3.0%) | 13613 / 174120 (7.8%) | −147.3 | −145.3 | 0.38 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 264 / 17412 (1.5%) | 9463 / 174120 (5.4%) | −146.7 | −144.6 | 0.28 |
| FOXA1 SRX3923515 | MCF-7 Breast | 216 / 17412 (1.2%) | 8606 / 174120 (4.9%) | −146.6 | −144.6 | 0.25 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 921 / 17412 (5.3%) | 19328 / 174120 (11.1%) | −146.4 | −144.4 | 0.48 |
| FOXA1 SRX1447317 | MCF-7 Breast | 260 / 17412 (1.5%) | 9371 / 174120 (5.4%) | −146.0 | −144.0 | 0.28 |
| FOSL2 SRX190296 | SK-N-SH Neural | 547 / 17412 (3.1%) | 13964 / 174120 (8.0%) | −145.9 | −143.9 | 0.39 |
| FOXA1 SRX3931032 | MCF-7 Breast | 225 / 17412 (1.3%) | 8742 / 174120 (5.0%) | −145.8 | −143.7 | 0.26 |
| CDK9 SRX7366781 | MCF-7 Breast | 237 / 17412 (1.4%) | 142 / 174120 (0.1%) | −145.7 | −143.7 | 16.69 |
| AR SRX9109113 | MDA-MB-453 Breast | 784 / 17412 (4.5%) | 17395 / 174120 (10.0%) | −145.7 | −143.6 | 0.45 |
| ESR1 SRX8537722 | MCF-7 Breast | 373 / 17412 (2.1%) | 11242 / 174120 (6.5%) | −145.4 | −143.4 | 0.33 |
| NKX2-1 SRX2164786 | A549 Lung | 677 / 17412 (3.9%) | 15855 / 174120 (9.1%) | −145.2 | −143.2 | 0.43 |
| VGLL1 SRX18013277 | FULVR Breast | 163 / 17412 (0.9%) | 7561 / 174120 (4.3%) | −144.8 | −142.8 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 441 / 17412 (2.5%) | 12297 / 174120 (7.1%) | −144.7 | −142.7 | 0.36 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1329 / 17412 (7.6%) | 5771 / 174120 (3.3%) | −144.5 | −142.5 | 2.30 |
| FOXA1 SRX1447316 | MCF-7 Breast | 159 / 17412 (0.9%) | 7474 / 174120 (4.3%) | −144.5 | −142.4 | 0.21 |
| FOXA1 SRX1961158 | T-47D Breast | 404 / 17412 (2.3%) | 11698 / 174120 (6.7%) | −144.2 | −142.2 | 0.35 |
| FOXA1 SRX5203303 | MCF-7 Breast | 124 / 17412 (0.7%) | 6761 / 174120 (3.9%) | −143.8 | −141.8 | 0.18 |
| GATAD2A SRX2636507 | Hep G2 Liver | 440 / 17412 (2.5%) | 12250 / 174120 (7.0%) | −143.8 | −141.8 | 0.36 |
| FOXA1 SRX5323830 | T-47D Breast | 235 / 17412 (1.3%) | 8859 / 174120 (5.1%) | −143.7 | −141.7 | 0.27 |
| FOXA1 SRX3931056 | MCF-7 Breast | 231 / 17412 (1.3%) | 8783 / 174120 (5.0%) | −143.7 | −141.7 | 0.26 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1584 / 17412 (9.1%) | 7515 / 174120 (4.3%) | −143.7 | −141.7 | 2.11 |
| PGR SRX1012655 | MCF-7 Breast | 256 / 17412 (1.5%) | 9224 / 174120 (5.3%) | −143.6 | −141.6 | 0.28 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1395 / 17412 (8.0%) | 6232 / 174120 (3.6%) | −143.4 | −141.4 | 2.24 |
| YAP1 SRX10119364 | MCF 10A Breast | 344 / 17412 (2.0%) | 10702 / 174120 (6.1%) | −143.4 | −141.4 | 0.32 |
| GFP SRX5417098 | HeLa Uterus | 477 / 17412 (2.7%) | 12806 / 174120 (7.4%) | −143.3 | −141.3 | 0.37 |
| ESR1 SRX4451213 | MCF-7 Breast | 411 / 17412 (2.4%) | 11778 / 174120 (6.8%) | −143.2 | −141.2 | 0.35 |
| SOX5 SRX2636544 | Hep G2 Liver | 407 / 17412 (2.3%) | 11702 / 174120 (6.7%) | −143.0 | −141.0 | 0.35 |
| ESR1 SRX1012629 | MCF-7 Breast | 251 / 17412 (1.4%) | 9114 / 174120 (5.2%) | −142.9 | −140.9 | 0.28 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 102 / 17412 (0.6%) | 6270 / 174120 (3.6%) | −142.8 | −140.8 | 0.16 |
| ESR1 SRX3123829 | MCF-7 Breast | 229 / 17412 (1.3%) | 8722 / 174120 (5.0%) | −142.7 | −140.7 | 0.26 |
| FOXA1 SRX9604647 | LNCAP Prostate | 627 / 17412 (3.6%) | 15011 / 174120 (8.6%) | −142.2 | −140.2 | 0.42 |
| PROX1 SRX3230397 | Hep G2 Liver | 293 / 17412 (1.7%) | 9813 / 174120 (5.6%) | −142.2 | −140.2 | 0.30 |
| ESR1 SRX1012632 | MCF-7 Breast | 195 / 17412 (1.1%) | 8078 / 174120 (4.6%) | −142.0 | −140.0 | 0.24 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 271 / 17412 (1.6%) | 9424 / 174120 (5.4%) | −141.8 | −139.8 | 0.29 |
| JUND SRX190357 | SK-N-SH Neural | 526 / 17412 (3.0%) | 13495 / 174120 (7.8%) | −141.7 | −139.8 | 0.39 |
| FOS SRX3322636 | MCF-7 Breast | 269 / 17412 (1.5%) | 9389 / 174120 (5.4%) | −141.7 | −139.8 | 0.29 |
| ESR1 SRX10365533 | MCF-7 Breast | 185 / 17412 (1.1%) | 7884 / 174120 (4.5%) | −141.7 | −139.7 | 0.23 |
| SREBF2 SRX5359048 | HCC70 Breast | 1633 / 17412 (9.4%) | 7903 / 174120 (4.5%) | −141.7 | −139.7 | 2.07 |
| ESR1 SRX1531796 | MCF-7 Breast | 212 / 17412 (1.2%) | 8378 / 174120 (4.8%) | −141.6 | −139.6 | 0.25 |
| JADE3 DRX300415 | 293 Kidney | 1480 / 17412 (8.5%) | 6848 / 174120 (3.9%) | −141.5 | −139.5 | 2.16 |
| ARID1A SRX5089391 | MCF-7 Breast | 225 / 17412 (1.3%) | 8607 / 174120 (4.9%) | −141.4 | −139.4 | 0.26 |
| FOXA1 SRX100477 | Hep G2 Liver | 467 / 17412 (2.7%) | 12578 / 174120 (7.2%) | −141.3 | −139.3 | 0.37 |
| FOXL2 SRX6957431 | KGN Gonad | 942 / 17412 (5.4%) | 19395 / 174120 (11.1%) | −141.1 | −139.2 | 0.49 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 708 / 17412 (4.1%) | 16136 / 174120 (9.3%) | −141.1 | −139.2 | 0.44 |
| ESR1 SRX8537723 | MCF-7 Breast | 327 / 17412 (1.9%) | 10336 / 174120 (5.9%) | −140.8 | −138.8 | 0.32 |
| FOXA2 SRX10475773 | Hep G2 Liver | 497 / 17412 (2.9%) | 13020 / 174120 (7.5%) | −140.7 | −138.8 | 0.38 |
| FOXA1 SRX1161205 | T-47D Breast | 217 / 17412 (1.2%) | 8431 / 174120 (4.8%) | −140.4 | −138.4 | 0.26 |
| ARID1A SRX5089385 | MCF-7 Breast | 308 / 17412 (1.8%) | 9994 / 174120 (5.7%) | −140.1 | −138.1 | 0.31 |
| ESR1 SRX2912055 | MCF-7 Breast | 147 / 17412 (0.8%) | 7109 / 174120 (4.1%) | −140.0 | −138.1 | 0.21 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 604 / 17412 (3.5%) | 14579 / 174120 (8.4%) | −139.8 | −137.8 | 0.41 |
| ARID1A SRX5089382 | MCF-7 Breast | 296 / 17412 (1.7%) | 9780 / 174120 (5.6%) | −139.7 | −137.8 | 0.30 |
| JUN SRX6582172 | Fibroblasts Others | 556 / 17412 (3.2%) | 13868 / 174120 (8.0%) | −139.7 | −137.7 | 0.40 |
| RELA SRX5938177 | FaDu Others | 384 / 17412 (2.2%) | 11214 / 174120 (6.4%) | −139.5 | −137.5 | 0.34 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 393 / 17412 (2.3%) | 11357 / 174120 (6.5%) | −139.4 | −137.5 | 0.35 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 156 / 17412 (0.9%) | 7255 / 174120 (4.2%) | −139.1 | −137.2 | 0.22 |
| FOXA3 SRX2630190 | Hep G2 Liver | 345 / 17412 (2.0%) | 10570 / 174120 (6.1%) | −139.1 | −137.1 | 0.33 |
| EP300 SRX1012648 | MCF-7 Breast | 190 / 17412 (1.1%) | 7897 / 174120 (4.5%) | −139.1 | −137.1 | 0.24 |
| EP300 SRX1012644 | MCF-7 Breast | 181 / 17412 (1.0%) | 7718 / 174120 (4.4%) | −138.7 | −136.8 | 0.23 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 331 / 17412 (1.9%) | 10327 / 174120 (5.9%) | −138.6 | −136.7 | 0.32 |
| ESR1 SRX1469949 | MCF-7 Breast | 231 / 17412 (1.3%) | 8622 / 174120 (5.0%) | −138.6 | −136.6 | 0.27 |
| ESR1 SRX5323871 | MCF-7 Breast | 455 / 17412 (2.6%) | 12297 / 174120 (7.1%) | −138.6 | −136.6 | 0.37 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 724 / 17412 (4.2%) | 2211 / 174120 (1.3%) | −137.9 | −136.0 | 3.27 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 230 / 17412 (1.3%) | 8584 / 174120 (4.9%) | −137.9 | −136.0 | 0.27 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1001 / 17412 (5.7%) | 20045 / 174120 (11.5%) | −137.8 | −135.9 | 0.50 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 764 / 17412 (4.4%) | 16793 / 174120 (9.6%) | −137.8 | −135.9 | 0.45 |
| NANOG SRX10445309 | Neural crest cells Neural | 226 / 17412 (1.3%) | 8506 / 174120 (4.9%) | −137.7 | −135.7 | 0.27 |
| AR SRX1067066 | LHSAR Prostate | 877 / 17412 (5.0%) | 18357 / 174120 (10.5%) | −137.6 | −135.7 | 0.48 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 320 / 17412 (1.8%) | 10099 / 174120 (5.8%) | −137.2 | −135.2 | 0.32 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 749 / 17412 (4.3%) | 2358 / 174120 (1.4%) | −137.0 | −135.1 | 3.18 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 363 / 17412 (2.1%) | 10785 / 174120 (6.2%) | −136.8 | −134.9 | 0.34 |
| ESR1 SRX330068 | MCF-7 Breast | 191 / 17412 (1.1%) | 7848 / 174120 (4.5%) | −136.8 | −134.8 | 0.24 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 271 / 17412 (1.6%) | 9250 / 174120 (5.3%) | −136.4 | −134.5 | 0.29 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 88 / 17412 (0.5%) | 5779 / 174120 (3.3%) | −136.3 | −134.4 | 0.15 |
| WWTR1 SRX10119378 | MCF 10A Breast | 460 / 17412 (2.6%) | 12286 / 174120 (7.1%) | −136.1 | −134.2 | 0.37 |
| FOSL2 SRX190204 | A549 Lung | 427 / 17412 (2.5%) | 11761 / 174120 (6.8%) | −135.8 | −133.9 | 0.36 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 453 / 17412 (2.6%) | 12163 / 174120 (7.0%) | −135.8 | −133.9 | 0.37 |
| ARID1A SRX5089388 | MCF-7 Breast | 213 / 17412 (1.2%) | 8217 / 174120 (4.7%) | −135.8 | −133.8 | 0.26 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 364 / 17412 (2.1%) | 10762 / 174120 (6.2%) | −135.7 | −133.8 | 0.34 |
| ESR1 SRX1012633 | MCF-7 Breast | 212 / 17412 (1.2%) | 8196 / 174120 (4.7%) | −135.7 | −133.8 | 0.26 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1822 / 17412 (10.5%) | 9408 / 174120 (5.4%) | −135.5 | −133.6 | 1.94 |
| FOXA1 SRX1787654 | MCF-7 Breast | 148 / 17412 (0.8%) | 6988 / 174120 (4.0%) | −135.4 | −133.4 | 0.21 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 680 / 17412 (3.9%) | 15502 / 174120 (8.9%) | −135.3 | −133.4 | 0.44 |
| FOXA1 SRX1161172 | MCF-7 Breast | 431 / 17412 (2.5%) | 11806 / 174120 (6.8%) | −135.3 | −133.4 | 0.37 |
| FOS SRX3322637 | MCF-7 Breast | 225 / 17412 (1.3%) | 8414 / 174120 (4.8%) | −135.3 | −133.3 | 0.27 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 499 / 17412 (2.9%) | 12843 / 174120 (7.4%) | −135.2 | −133.3 | 0.39 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1660 / 17412 (9.5%) | 8250 / 174120 (4.7%) | −135.1 | −133.2 | 2.01 |
| TP53 SRX19538272 | U2OS Bone | 514 / 17412 (3.0%) | 1189 / 174120 (0.7%) | −134.9 | −133.0 | 4.32 |
| EP300 SRX2194266 | SUM 159PT Breast | 734 / 17412 (4.2%) | 16253 / 174120 (9.3%) | −134.9 | −133.0 | 0.45 |
| KMT2C SRX1787675 | MCF-7 Breast | 374 / 17412 (2.1%) | 10892 / 174120 (6.3%) | −134.9 | −132.9 | 0.34 |
| HMG20A SRX2630163 | Hep G2 Liver | 237 / 17412 (1.4%) | 8611 / 174120 (4.9%) | −134.8 | −132.9 | 0.28 |
| ESR1 SRX20282959 | MCF-7 Breast | 171 / 17412 (1.0%) | 7413 / 174120 (4.3%) | −134.7 | −132.8 | 0.23 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 673 / 17412 (3.9%) | 15360 / 174120 (8.8%) | −134.3 | −132.4 | 0.44 |
| AR SRX1067067 | LHSAR Prostate | 719 / 17412 (4.1%) | 16009 / 174120 (9.2%) | −134.1 | −132.2 | 0.45 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 478 / 17412 (2.7%) | 12482 / 174120 (7.2%) | −134.1 | −132.2 | 0.38 |
| FOXA1 SRX1161207 | T-47D Breast | 170 / 17412 (1.0%) | 7369 / 174120 (4.2%) | −133.9 | −132.0 | 0.23 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 516 / 17412 (3.0%) | 1207 / 174120 (0.7%) | −133.9 | −132.0 | 4.28 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1498 / 17412 (8.6%) | 7145 / 174120 (4.1%) | −133.9 | −132.0 | 2.10 |
| FOXA1 SRX9604645 | LNCAP Prostate | 601 / 17412 (3.5%) | 14303 / 174120 (8.2%) | −133.8 | −131.9 | 0.42 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 813 / 17412 (4.7%) | 17307 / 174120 (9.9%) | −133.7 | −131.8 | 0.47 |
| ESR1 SRX4451212 | MCF-7 Breast | 401 / 17412 (2.3%) | 11279 / 174120 (6.5%) | −133.7 | −131.8 | 0.36 |
| JUNB SRX10119384 | MCF 10A Breast | 267 / 17412 (1.5%) | 9084 / 174120 (5.2%) | −133.5 | −131.6 | 0.29 |
| JUND SRX092301 | K-562 Blood | 566 / 17412 (3.3%) | 13772 / 174120 (7.9%) | −133.4 | −131.5 | 0.41 |
| NFIL3 SRX2630334 | Hep G2 Liver | 340 / 17412 (2.0%) | 10293 / 174120 (5.9%) | −133.3 | −131.4 | 0.33 |
| Epitope tags SRX5877914 | U2OS Bone | 2260 / 17412 (13.0%) | 35570 / 174120 (20.4%) | −133.2 | −131.3 | 0.64 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 754 / 17412 (4.3%) | 16464 / 174120 (9.5%) | −133.2 | −131.3 | 0.46 |
| VGLL1 SRX18013279 | FULVR Breast | 200 / 17412 (1.1%) | 7896 / 174120 (4.5%) | −133.1 | −131.2 | 0.25 |
| FOXA1 SRX5203294 | MCF-7 Breast | 113 / 17412 (0.6%) | 6219 / 174120 (3.6%) | −133.0 | −131.1 | 0.18 |
| ESR1 SRX1469951 | MCF-7 Breast | 216 / 17412 (1.2%) | 8182 / 174120 (4.7%) | −133.0 | −131.1 | 0.26 |
| ESR1 SRX11120903 | MCF-7 Breast | 370 / 17412 (2.1%) | 10760 / 174120 (6.2%) | −132.9 | −131.0 | 0.34 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 501 / 17412 (2.9%) | 12782 / 174120 (7.3%) | −132.7 | −130.8 | 0.39 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 150 / 17412 (0.9%) | 6945 / 174120 (4.0%) | −132.6 | −130.7 | 0.22 |
| JADE3 DRX234809 | 293 Kidney | 979 / 17412 (5.6%) | 3760 / 174120 (2.2%) | −132.5 | −130.6 | 2.60 |
| NFYB SRX16608147 | HeLa Uterus | 250 / 17412 (1.4%) | 213 / 174120 (0.1%) | −132.4 | −130.5 | 11.74 |
| RNF2 SRX18954719 | SCC-25 Others | 577 / 17412 (3.3%) | 13896 / 174120 (8.0%) | −132.4 | −130.5 | 0.42 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 587 / 17412 (3.4%) | 14042 / 174120 (8.1%) | −132.3 | −130.5 | 0.42 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 576 / 17412 (3.3%) | 13879 / 174120 (8.0%) | −132.3 | −130.5 | 0.42 |
| KAT7 DRX300414 | 293 Kidney | 599 / 17412 (3.4%) | 1623 / 174120 (0.9%) | −132.3 | −130.4 | 3.69 |
| ESR1 SRX10365534 | MCF-7 Breast | 118 / 17412 (0.7%) | 6301 / 174120 (3.6%) | −132.2 | −130.3 | 0.19 |
| ESR1 SRX2513521 | MCF-7 Breast | 199 / 17412 (1.1%) | 7844 / 174120 (4.5%) | −132.0 | −130.1 | 0.25 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 818 / 17412 (4.7%) | 17304 / 174120 (9.9%) | −131.9 | −130.1 | 0.47 |
| JUNB SRX8488074 | SUM 229PE Breast | 586 / 17412 (3.4%) | 14007 / 174120 (8.0%) | −131.8 | −129.9 | 0.42 |
| KMT2A SRX2323891 | 293 Kidney | 930 / 17412 (5.3%) | 3475 / 174120 (2.0%) | −131.8 | −129.9 | 2.68 |
| JUNB SRX10119383 | MCF 10A Breast | 304 / 17412 (1.7%) | 9648 / 174120 (5.5%) | −131.7 | −129.9 | 0.32 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 151 / 17412 (0.9%) | 6938 / 174120 (4.0%) | −131.7 | −129.8 | 0.22 |
| STAT3 SRX150479 | MCF 10A Breast | 405 / 17412 (2.3%) | 11269 / 174120 (6.5%) | −131.7 | −129.8 | 0.36 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1723 / 17412 (9.9%) | 8793 / 174120 (5.0%) | −131.6 | −129.7 | 1.96 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 279 / 17412 (1.6%) | 9222 / 174120 (5.3%) | −131.5 | −129.7 | 0.30 |
| FOXA1 SRX6860635 | T-47D Breast | 327 / 17412 (1.9%) | 10016 / 174120 (5.8%) | −131.4 | −129.6 | 0.33 |
| ESR1 SRX5323878 | MCF-7 Breast | 433 / 17412 (2.5%) | 11696 / 174120 (6.7%) | −131.4 | −129.5 | 0.37 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 176 / 17412 (1.0%) | 7401 / 174120 (4.3%) | −131.4 | −129.5 | 0.24 |
| GATA2 SRX16314544 | Trophoblast stem cells Placenta | 268 / 17412 (1.5%) | 9025 / 174120 (5.2%) | −131.2 | −129.3 | 0.30 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 604 / 17412 (3.5%) | 14243 / 174120 (8.2%) | −131.2 | −129.3 | 0.42 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 330 / 17412 (1.9%) | 10055 / 174120 (5.8%) | −131.1 | −129.3 | 0.33 |
| CEBPA SRX4705113 | MOLM-13 Blood | 978 / 17412 (5.6%) | 19436 / 174120 (11.2%) | −131.0 | −129.1 | 0.50 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 355 / 17412 (2.0%) | 10451 / 174120 (6.0%) | −131.0 | −129.1 | 0.34 |
| FOXA1 SRX5203307 | MCF-7 Breast | 121 / 17412 (0.7%) | 6321 / 174120 (3.6%) | −130.9 | −129.0 | 0.19 |
| FOXA1 SRX3931031 | MCF-7 Breast | 198 / 17412 (1.1%) | 7784 / 174120 (4.5%) | −130.7 | −128.9 | 0.25 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 650 / 17412 (3.7%) | 14888 / 174120 (8.6%) | −130.7 | −128.8 | 0.44 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 456 / 17412 (2.6%) | 12021 / 174120 (6.9%) | −130.7 | −128.8 | 0.38 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 787 / 17412 (4.5%) | 16818 / 174120 (9.7%) | −130.7 | −128.8 | 0.47 |
| Epitope tags SRX20741925 | Hep G2 Liver | 738 / 17412 (4.2%) | 16133 / 174120 (9.3%) | −130.6 | −128.8 | 0.46 |
| STAT3 SRX150630 | MCF 10A Breast | 404 / 17412 (2.3%) | 11214 / 174120 (6.4%) | −130.5 | −128.7 | 0.36 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 215 / 17412 (1.2%) | 8081 / 174120 (4.6%) | −130.5 | −128.6 | 0.27 |
| ESR1 SRX2513517 | MCF-7 Breast | 294 / 17412 (1.7%) | 9438 / 174120 (5.4%) | −130.5 | −128.6 | 0.31 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 630 / 17412 (3.6%) | 14589 / 174120 (8.4%) | −130.4 | −128.5 | 0.43 |
| VGLL1 SRX18013278 | FULVR Breast | 207 / 17412 (1.2%) | 7929 / 174120 (4.6%) | −130.2 | −128.3 | 0.26 |
| ZEB1 SRX13298924 | MCF-7 Breast | 207 / 17412 (1.2%) | 7928 / 174120 (4.6%) | −130.2 | −128.3 | 0.26 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 618 / 17412 (3.5%) | 14381 / 174120 (8.3%) | −129.4 | −127.6 | 0.43 |
| SP1 SRX190358 | HCT 116 Digestive tract | 668 / 17412 (3.8%) | 15097 / 174120 (8.7%) | −129.4 | −127.6 | 0.44 |
| NR3C1 SRX19024866 | MCF-7 Breast | 146 / 17412 (0.8%) | 6771 / 174120 (3.9%) | −129.3 | −127.5 | 0.22 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 535 / 17412 (3.1%) | 1340 / 174120 (0.8%) | −129.1 | −127.3 | 3.99 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 751 / 17412 (4.3%) | 16253 / 174120 (9.3%) | −129.1 | −127.3 | 0.46 |
| AR SRX9109109 | MDA-MB-453 Breast | 511 / 17412 (2.9%) | 12795 / 174120 (7.3%) | −129.1 | −127.2 | 0.40 |
| EP300 SRX1012643 | MCF-7 Breast | 154 / 17412 (0.9%) | 6917 / 174120 (4.0%) | −129.0 | −127.2 | 0.22 |
| FOXA1 SRX5323846 | MCF-7 Breast | 163 / 17412 (0.9%) | 7087 / 174120 (4.1%) | −129.0 | −127.1 | 0.23 |
| EOMES SRX035159 | hESC derived mesendodermal cells Pluripotent stem cell | 294 / 17412 (1.7%) | 9385 / 174120 (5.4%) | −128.9 | −127.1 | 0.31 |
| RXRB SRX2636027 | Hep G2 Liver | 473 / 17412 (2.7%) | 12204 / 174120 (7.0%) | −128.7 | −126.8 | 0.39 |
| FOXA1 SRX5323845 | MCF-7 Breast | 157 / 17412 (0.9%) | 6961 / 174120 (4.0%) | −128.6 | −126.8 | 0.23 |
| EP300 SRX100540 | SK-N-SH Neural | 633 / 17412 (3.6%) | 14553 / 174120 (8.4%) | −128.4 | −126.6 | 0.43 |
| ESR1 SRX2513520 | MCF-7 Breast | 272 / 17412 (1.6%) | 9003 / 174120 (5.2%) | −128.4 | −126.5 | 0.30 |
| TRPS1 SRX3401273 | MCF-7 Breast | 140 / 17412 (0.8%) | 6625 / 174120 (3.8%) | −128.3 | −126.4 | 0.21 |
| MEN1 SRX11712604 | K-562 Blood | 1341 / 17412 (7.7%) | 6198 / 174120 (3.6%) | −128.0 | −126.1 | 2.16 |
| SS18 SRX10881848 | G-401 Kidney | 583 / 17412 (3.3%) | 13812 / 174120 (7.9%) | −128.0 | −126.1 | 0.42 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 677 / 17412 (3.9%) | 15163 / 174120 (8.7%) | −127.9 | −126.1 | 0.45 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 83 / 17412 (0.5%) | 5432 / 174120 (3.1%) | −127.7 | −125.9 | 0.15 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 1057 / 17412 (6.1%) | 20344 / 174120 (11.7%) | −127.7 | −125.9 | 0.52 |
| JUND SRX150648 | K-562 Blood | 579 / 17412 (3.3%) | 13747 / 174120 (7.9%) | −127.7 | −125.9 | 0.42 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1031 / 17412 (5.9%) | 4171 / 174120 (2.4%) | −127.5 | −125.7 | 2.47 |
| MITF SRX1555436 | 501A Epidermis | 1848 / 17412 (10.6%) | 9820 / 174120 (5.6%) | −127.3 | −125.4 | 1.88 |
| STAT3 SRX150536 | MCF 10A Breast | 495 / 17412 (2.8%) | 12484 / 174120 (7.2%) | −127.2 | −125.4 | 0.40 |
| ESR1 SRX5323872 | MCF-7 Breast | 439 / 17412 (2.5%) | 11635 / 174120 (6.7%) | −127.2 | −125.3 | 0.38 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 316 / 17412 (1.8%) | 9687 / 174120 (5.6%) | −127.1 | −125.3 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 185 / 17412 (1.1%) | 7429 / 174120 (4.3%) | −126.9 | −125.0 | 0.25 |
| ZNF219 SRX3230413 | Hep G2 Liver | 746 / 17412 (4.3%) | 16088 / 174120 (9.2%) | −126.8 | −125.0 | 0.46 |
| FOXA1 SRX3923511 | MCF-7 Breast | 168 / 17412 (1.0%) | 7110 / 174120 (4.1%) | −126.8 | −125.0 | 0.24 |
| ESR1 SRX5323877 | MCF-7 Breast | 347 / 17412 (2.0%) | 10175 / 174120 (5.8%) | −126.8 | −124.9 | 0.34 |
| RNF2 SRX18954704 | FaDu Others | 1021 / 17412 (5.9%) | 19809 / 174120 (11.4%) | −126.5 | −124.6 | 0.52 |
| TEAD1 SRX2636000 | Hep G2 Liver | 255 / 17412 (1.5%) | 8645 / 174120 (5.0%) | −126.4 | −124.6 | 0.29 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 369 / 17412 (2.1%) | 10504 / 174120 (6.0%) | −126.1 | −124.3 | 0.35 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 126 / 17412 (0.7%) | 6279 / 174120 (3.6%) | −126.0 | −124.1 | 0.20 |
| ESR1 SRX792933 | LY2 Breast | 363 / 17412 (2.1%) | 10407 / 174120 (6.0%) | −126.0 | −124.1 | 0.35 |
| ESR1 SRX1012625 | MCF-7 Breast | 232 / 17412 (1.3%) | 8228 / 174120 (4.7%) | −125.8 | −123.9 | 0.28 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 593 / 17412 (3.4%) | 13867 / 174120 (8.0%) | −125.6 | −123.8 | 0.43 |
| FOXA1 SRX219284 | LNCAP Prostate | 596 / 17412 (3.4%) | 13908 / 174120 (8.0%) | −125.6 | −123.8 | 0.43 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 334 / 17412 (1.9%) | 9925 / 174120 (5.7%) | −125.5 | −123.7 | 0.34 |
| RELA SRX7055007 | HAEC Cardiovascular | 799 / 17412 (4.6%) | 16766 / 174120 (9.6%) | −125.5 | −123.6 | 0.48 |
| EP300 ERX626821 | U-937 Blood | 1164 / 17412 (6.7%) | 5068 / 174120 (2.9%) | −125.4 | −123.6 | 2.30 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 345 / 17412 (2.0%) | 10092 / 174120 (5.8%) | −125.3 | −123.5 | 0.34 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1811 / 17412 (10.4%) | 9607 / 174120 (5.5%) | −125.2 | −123.4 | 1.89 |
| ESR1 SRX5534831 | MCF-7 Breast | 347 / 17412 (2.0%) | 10120 / 174120 (5.8%) | −125.2 | −123.3 | 0.34 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 453 / 17412 (2.6%) | 11771 / 174120 (6.8%) | −125.1 | −123.3 | 0.38 |
Showing first 500 of 18263 rows.